Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease-Reference-Cited by-同舟云学术

Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease

Published:2024-01 Issue:1 Volume:11 Page:67-71
ISSN:2352-3042
Container-title:Genes & Diseases
language:en
Short-container-title:Genes & Diseases

Author:

Kar Souvik^ORCID,Perrelli Andrea^ORCID,Bali Kiran Kumar^ORCID,Mastrocola Raffaella^ORCID,Kar Arpita,Khan Bushra,Gand Luis,Nayak Arnab,Hartmann Christian,Kunz Wolfram S.^ORCID,Samii Amir,Bertalanffy Helmut,Retta Saverio Francesco^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Genetics (clinical),Molecular Biology,Biochemistry

Reference5 articles.

1. Polymorphisms in genes related to oxidative stress and inflammation: emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease;Perrelli;Free Radic Biol Med,2021

2. KRIT1: a traffic warden at the busy crossroads between redox signaling and the pathogenesis of cerebral cavernous malformation disease;Perrelli;Antioxidants Redox Signal,2023

3. Galectin-3: an emerging biomarker in stroke and cerebrovascular diseases;Venkatraman;Eur J Neurol,2018

4. Transcriptome-wide profiling of cerebral cavernous malformations patients reveal important long noncoding RNA molecular signatures;Subhash;Sci Rep,2019

5. Microglia-secreted galectin-3 acts as a Toll-like receptor 4 ligand and contributes to microglial activation;Burguillos;Cell Rep,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic variants in FCGR2A, PTPN2, VDR as predictive signatures of aggressive phenotypes in cerebral cavernous malformation;Gene;2025-01

2. Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment;Frontiers in Neuroscience;2024-08-21

3. Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

4. Plasma water T2 detects age-stratified differences in cardiometabolic health among familial CCM patients with Hispanic CCM1 mutation;Metabolic Brain Disease;2024-05-25